Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type 1 selected

Type

Guidance programme

Guidance programme

HealthTech approach

HealthTech approach

Area of interest

Showing 131 to 140 of 2039

TitleReference numberPublishedLast updated
Letermovir for preventing cytomegalovirus infection after a kidney transplant (terminated appraisal)TA1082
Lisocabtagene maraleucel for treating relapsed or refractory aggressive B-cell non-Hodgkin lymphoma after 1 systemic treatment when a stem cell transplant is unsuitable (terminated appraisal)TA1083
Idecabtagene vicleucel for treating relapsed or refractory multiple myeloma after 2 to 4 treatments (terminated appraisal)TA1084
Fruquintinib for previously treated metastatic colorectal cancerTA1079
Mirikizumab for previously treated moderately to severely active Crohn's diseaseTA1080
Zanubrutinib for treating relapsed or refractory mantle cell lymphomaTA1081
One-piece closed bags for colostomies: late-stage assessmentHTG754
Pulsed-field ablation for atrial fibrillationHTG755
Intermittent urethral catheters for chronic incomplete bladder emptying in adults: late-stage assessmentHTG753
Dapagliflozin for treating chronic kidney diseaseTA1075

Results per page

  1. 10
  2. 25
  3. 50
  4. All